ReproCELL Incorporated
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
ReproCELL Incorporated made a loss over the last year. ReproCELL Incorporated owes ¥0.07 for every ¥1 it owns. ReproCELL Incorporated made a loss in the year to Mar 2026, after a profit the year before.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossReproCELL Incorporated made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.32The share price is 1.32 times ReproCELL Incorporated's book value per share, lower than 61% of Healthcare companies in Japan.
Market cap
¥12.0 BThe total market value of all of ReproCELL Incorporated's shares at today's price (share price × number of shares), smaller than 58% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥9.1 BWhat ReproCELL Incorporated would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥92.61Net worth divided by the number of shares. The share price of ¥122.00 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
-4.9%ReproCELL Incorporated lost 4.9% of its shareholders' money over the last year, lower than 76% of Healthcare companies in Japan.
Owes vs Owns
0.07×ReproCELL Incorporated owes ¥0.07 for every ¥1 it owns (low), lower than 96% of Healthcare companies in Japan.
Dividend yield
NoneReproCELL Incorporated does not currently pay a dividend.
Revenue growth
-25%Revenue fell 25% in the year to Mar 2026, and shrank 9% a year on average over 3 years.
Profit growth
LossReproCELL Incorporated made a loss in the year to Mar 2026, after a profit the year before.
Profit margin
-26.5%ReproCELL Incorporated lost ¥26 for every ¥100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For ReproCELL Incorporated: ¥12.0 B ÷ ¥9.1 B (30 Jun 2026) = 1.3.
What is ReproCELL Incorporated's return on equity?
ReproCELL Incorporated lost 4.9% of its shareholders' money over the last year, lower than 76% of Healthcare companies in Japan.
How much does ReproCELL Incorporated owe compared with what it owns?
ReproCELL Incorporated owes ¥0.07 for every ¥1 it owns (low), lower than 96% of Healthcare companies in Japan.
Does ReproCELL Incorporated pay a dividend?
No. ReproCELL Incorporated does not currently pay a dividend.
Is ReproCELL Incorporated's revenue growing?
Revenue fell 25% in the year to Mar 2026, and shrank 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.